May 28, 2019 6:00 am EDT NeoGenomics and QIAGEN Collaborate to Offer Companion Diagnostic Test for HR+/HER2 - Advanced Breast Cancer Patients to Detect a PIK3CA Mutation
May 23, 2019 4:30 pm EDT NeoGenomics To Attend The 16th Annual Craig-Hallum Institutional Investor Conference
Apr 30, 2019 7:00 am EDT NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter
Apr 2, 2019 5:20 pm EDT NeoGenomics to Present at 18th Annual Needham & Company Health Care Conference
Mar 11, 2019 7:00 am EDT NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQ(R)
Mar 7, 2019 4:50 pm EST NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference
